MDR
Medadvisor Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The Company’s segments include Australia, the United States, the United Kingdom and Asia Operations. Its product suite is built upon a medication data platform that supports a patient app, a pharmacy-based module PlusOne, and digital health programs, all of which are connected to dispensing networks. The company provides one-tap access to the details of the pharmacy, including phone number, email, opening hours and show-on-map/navigation. The Company’s subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.
📈 Performance
Price History
+122.73%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.24
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in MDR
5
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in MDR
508 days
MDR investor breakdown
💵 Income of investors
More than 200k
14%
150k - 200k
100k - 150k
57%
50k - 100k
Less than 50k
29%
👶 Age of investors
18 - 25
20%
26 - 34
35 - 90
80%
🙋 Legal gender of investors
Female
20%
Male
80%
Pearlers who invest in MDR also invest in...
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
📊 Share price
$43.11 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
Volpara Health Technologies Ltd. engages in selling the VolparaEnterprise software, which is a cloud-based breast imaging analytics product. The firm provides its goods and services under three product categories: software as a service (SaaS) contract, software maintenance agreements (SMAs) and capital sales contracts. Software as a service (SaaS) contract involves the sale of software on a subscription basis and, where applicable, cloud-based support. SaaS contracts comprise a range of goods and services, including the base software, software updates and upgrades, installation, integrations, and other. Software maintenance agreements (SMAs) support previous capital sales. SMA contracts comprise a number of distinct performance obligations, including the provision of software updates, upgrades, provision of ongoing technical support, and other. Capital sales contracts involve the outright sale of software and associated items.
📊 Share price
$0.76 AUD
NULL HEALTH
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
VHY.AX was created on 2011-05-26 by Vanguard. The fund's investment portfolio concentrates primarily on high dividend yield equity. Vanguard Australian Shares High Yield ETF seeks to track the return of the FTSE Australia High Dividend Yield Index before taking into account fees, expenses and tax.
📊 Share price
$66.86 AUD
NULL AUSTRALIA
NULL BETA
NULL INCOME
Want more shares? Try these...
Mindax Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-12-08. The Company’s portfolio of projects includes iron ore and gold. Its projects include the Mt Forrest Iron Project, Mt Lucky Gold project and Meekatharra North Project. The Mt Forrest iron project is in the Yilgarn province. The company comprises seven mining leases and is located 600 kilometers (km) from the Port of Geraldton and 165 km from the southbound railway at Menzies and around 648 km from the port at Esperance. The project is a world-scale iron ore resource. The Meekatharra North Project comprises one granted exploration license, E51/1705. The Meekatharra North Project is a gold-mining center in the Murchison Goldfields of Western Australia. The project is located 40 km north of the township of Meekatharra, at the northern end of the Meekatharra Greenstone Belt, in the Murchison Province, Western Australia. Mt Lucky lies within the Mt Margaret Mineral Field of the north-eastern Goldfields of Western Australia.
📊 Share price
$0.10 AUD
McGrath Ltd. engages in the provision of residential real estate services, which includes residential property sales, property management, mortgage broking, auction services, and real estate training. The company is headquartered in Sydney, New South Wales and currently employs 273 full-time employees. The company went IPO on 2015-12-07. The firm is engaged in providing residential property sales, property management, residential project marketing, mortgage broking, auction services and career training. The Company’s segments include Company owned sales, Company owned property management, Franchise services, and Other services and investments. The firm owned sales segment undertakes residential property sales on behalf of property vendors through Company owned offices and agents. The firm owned property management segment directly manages residential properties on behalf of owner’s clients. The Franchise services segment manages franchise offices that undertake both property sales and property management activities. The Other services and investments segment has several other services and investments, which complement the service offerings of the segments. Its services include projects, new land estates, rural and livestock and home loans.
📊 Share price
$0.40 AUD
Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. The firm is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.
📊 Share price
$6.60 AUD
Middle Island Resources Ltd. engages in the acquisition, exploration and development of gold deposits. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-16. The firm operates through two segments: Australia and West Africa. The Company’s Barkly Copper-Gold Super Project comprises of 14 exploration licenses granted and two pending applications, which covers approximately 5,510 square kilometers (km2) within the Barkly region of the Northern Territory (NT).
📊 Share price